- Research works
- 63 ▲ 118% vs 2013–17
- Citations
- 1k 16.2 per fractional work
- Top-10% rate
- 19.9% record average 16.5%
- Open access
- 43% world 28%
Not ranked overall: Myovant Sciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Myovant Sciences (United States) specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.7× the share of its output that it takes of world research.
- MedicineField · 20.5 works4.7×
- Health SciencesDomain · 20.9 works4.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.7×. Every wedge is a field page.
Who are the top researchers at Myovant Sciences (United States)?
Ranked on the composite score, Lawrence Friedhoff lead among researchers whose main affiliation is Myovant Sciences (United States).
- 1 Lawrence Friedhoff United States · #295,382 worldwide 230 citations · 15 works
Which keywords describe research at Myovant Sciences (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Health-related Quality of Life, Uterine Fibroids, Uterine Leiomyoma, Surgical Treatment, Hormone Therapy and Prostate Cancer.
- Metabolic Syndrome
- Hysteroscopic Treatment
- Lower Urinary Tract Symptoms
- Metastatic Prostate Cancer
- Androgen Receptor
- Clinical Trials
- Urinary Incontinence
- Immunobiology
- Management
- Diagnosis
- Prostate Cancer
- Uterine Leiomyoma
- Surgical Treatment
- Quality of Life
- Epidemiology
- Health-related Quality of Life
- Uterine Fibroids
- Hormone Therapy
- Immunotherapy
- Infertility
- Pathophysiology
- Stem Cells
- Biomarkers
- Genomic Profiling
- Genetic Mutations
- Benign Prostatic Hyperplasia
- Reproductive Outcome
- Uterine Anomalies
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 28 words, with their numbers
- Epidemiology9▲ 9.5×14 topics
- Quality of Life4▲ 12×5 topics
- Health-related Quality of Life4▲ 69×2 topics
- Surgical Treatment4▲ 78×2 topics
- Uterine Fibroids4▲ 523×1 topic
- Uterine Leiomyoma4▲ 523×1 topic
- Hormone Therapy3▲ 182×3 topics
- Prostate Cancer3▲ 105×2 topics
- Immunotherapy3▲ 18×5 topics
- Diagnosis3▲ 14×5 topics
- Infertility3▲ 88×2 topics
- Management3▲ 16×3 topics
- Pathophysiology3▲ 41×2 topics
- Immunobiology3▲ 253×1 topic
- Stem Cells3▲ 47×1 topic
- Urinary Incontinence3▲ 153×2 topics
- Biomarkers2▲ 16×3 topics
- Clinical Trials2▲ 16×2 topics
- Genomic Profiling2▲ 106×2 topics
- Androgen Receptor2▲ 145×1 topic
- Genetic Mutations2▲ 25×2 topics
- Metastatic Prostate Cancer2▲ 261×1 topic
- Benign Prostatic Hyperplasia2▲ 264×1 topic
- Lower Urinary Tract Symptoms2▲ 264×1 topic
- Reproductive Outcome2▲ 201×2 topics
- Hysteroscopic Treatment2▲ 288×1 topic
- Uterine Anomalies2▲ 288×1 topic
- Metabolic Syndrome1▲ 6.0×4 topics
Which research topics does Myovant Sciences (United States) publish most on?
By volume in 2022–2025: Uterine Myomas and Treatments, Endometriosis Research and Treatment, Prostate Cancer Treatment and Research and Urinary Bladder and Prostate Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Uterine Myomas and Treatments Obstetrics and Gynecology 4 works
- 2 Endometriosis Research and Treatment Reproductive Medicine 3 works
- 3 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 2 works
- 4 Urinary Bladder and Prostate Research Urology 2 works
- 5 Gynecological conditions and treatments Obstetrics and Gynecology 2 works
- 6 Pelvic floor disorders treatments Rheumatology 1 works
- 7 Hormonal and reproductive studies Endocrinology, Diabetes and Metabolism 1 works
- 8 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 9 Urinary Tract Infections Management Epidemiology 1 works
- 10 Estrogen and related hormone effects Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Myovant Sciences (United States)'s research output changed?
Output in 2018–2022 was 118% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Brisbane
- Hitachi (United States)
- Second Genome (United States)
- Mammoth Biosciences (United States)
- Dance Biopharm (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.